Medical Engineering & Physics
Volume 34, Issue 1 , Pages 2-8 , January 2012

Effects of glucocorticoid on BMD, micro-architecture and biomechanics of cancellous and cortical bone mass in OVX rabbits

  • Xuli Liu

      Affiliations

    • Department of Orthopaedics, Xijing Hospital, the Fourth Military Medical University, 15 Changle West Road, Xian 710032, Shaanxi, China
  • ,
  • Wei Lei

      Affiliations

    • Department of Orthopaedics, Xijing Hospital, the Fourth Military Medical University, 15 Changle West Road, Xian 710032, Shaanxi, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 029 84771011; fax: +86 029 84771011.
  • ,
  • Zixiang Wu

      Affiliations

    • Department of Orthopaedics, Xijing Hospital, the Fourth Military Medical University, 15 Changle West Road, Xian 710032, Shaanxi, China
  • ,
  • Yi Cui

      Affiliations

    • Department of Orthopaedics, Xijing Hospital, the Fourth Military Medical University, 15 Changle West Road, Xian 710032, Shaanxi, China
  • ,
  • Baojun Han

      Affiliations

    • Department of Orthopaedics, Xijing Hospital, the Fourth Military Medical University, 15 Changle West Road, Xian 710032, Shaanxi, China
  • ,
  • Suochao Fu

      Affiliations

    • Department of Orthopaedics, Xijing Hospital, the Fourth Military Medical University, 15 Changle West Road, Xian 710032, Shaanxi, China
  • ,
  • Changli Jiang

      Affiliations

    • Clinical Lab, Kunming General Hospital of Chengdu Military Area Command of Chinese PLA, Daguan Roast, Kunming, Yunnan 650032, China

Received 10 December 2010 ,Revised 12 May 2011 ,Accepted 18 June 2011.

References 

  1. Adachi JD, Loannidis G, Berger C, Joseph L, Papaioannou A, Pickard L, et al. The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int. 2001;12(11):903–908
  2. Hall SE, Criddle RA, Comito TL, Prince RL. A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporos Int. 1999;9(6):508–515
  3. Lyles KW, Gold DT, Shipp KM, Pieper CF, Martinez S, Mulhausen PL. Association of osteoporotic vertebral compression fractures with impaired functional status. Am J Med. 1993;94(6):595–601
  4. Geddes AD. Animals models of bone disease. In:  Bilezikians JP,  Raisz LG,  Rodan GA editor. Principals of Bone Biology. San Diego: Academic Press; 1996;p. 1343–1354
  5. Bonjour JP, Ammann P, Rizzoli R. Importance of preclinical studies in the development of drugs for treatment of osteoporosis: a review related to the 1998 WHO guidelines. Osteoporos Int. 1999;9(5):379–393
  6. Egermann M, Goldhahn J, Schneider E. Animal models for fracture treatment in osteoporosis. Osteoporos Int. 2005;16(2):S129–S138
  7. Food and Drug Administration . Guidelines for Preclinical and Clinical Evaluation Agents Used in the Prevention or Treatment of Postmenopausal Osteoporosis. Rockville, MD, USA: Division of Metabolic and Endocrine Drug Products, Food and Drug Administration; 1994;
  8. Kalu DN. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 1991;15(3):175–191
  9. Wronski TJ, Yen CF. The ovariectomized rat as an animal model for postmenopausal bone loss. Cells Mater. 1992;129(4):69–74
  10. Mosekilde L. Assessing bone quality – animal models in preclinical osteoporosis research. Bone. 1995;17(4 Suppl.):S343–S352
  11. Turner RT, Maran A, Lotinun S, Hefferan T, Evans GL, Zhang M, et al. Animal models for osteoporosis. Rev Endocr Metab Disord. 2001;2(1):117–127
  12. Turner AS. Animal models of osteoporosis – necessity and limitations. Eur Cell Mater. 2001;1:66–81
  13. Reinwald S, Burr D. Review of nonprimate, large animal models for osteoporosis research. J Bone Miner Res. 2008;23(9):1353–1368
  14. Mori H, Manabe M, Kurachi Y, Nagumo M. Osseointegration of dental implants in rabbit bone with low mineral density. J Oral Maxillofac Surg. 1997;55(4):351–361discussion 362
  15. Zaffe D, Rodriguez YBR, Rizzo S, Brusotti C, Soncini M, Pietrabissa R, et al. Behavior of the bone–titanium interface after push-in testing: a morphological study. Biomed Mater Res J A. 2003;64(2):365–371
  16. Deglurkar M, Davy DT, Stewart M, Goldberg VM, Welter JF. Evaluation of machining methods for trabecular metal implants in a rabbit intramedullary osseointegration model. J Biomed Mater Res B: Appl Biomater. 2007;80(2):528–540
  17. Gilsanz V, Roe TF, Gibbens DT, Schulz EE, Carlson ME, Gonzalez O, et al. Effect of sex steroids on peak bone density of growing rabbits. Am J Physiol. 1988;255(4 Pt 1):E416–E421
  18. Kimmel DB. Animal models for in vivo experimentation in osteoporosis research. In:  Marcus R,  Feldman D,  Kelsey J editor. Osteoporosis. San Diego: Academic Press; 1996;p. 671–690
  19. Lindgren JU, DeLuca HF, Mazess RB. Effects of 1,25(OH)2D3 on bone tissue in the rabbit: studies on fracture healing, disuse osteoporosis, and prednisone osteoporosis. Calcif Tissue Int. 1984;36(5):591–595
  20. Cao T, Shirota T, Ohno K, Michi KI. Mineralized bone loss in partially edentulous trabeculae of ovariectomized rabbit mandibles. J Periodontal Res. 2004;39(1):37–41
  21. Cao T, Shirota T, Yamazaki M, Ohno K, Michi KI. Bone mineral density in mandibles of ovariectomized rabbits. Clin Oral Implants Res. 2001;12(6):604–608
  22. Castaneda S, Largo R, Calvo E, Rodriguez-Salvanes F, Marcos ME, Diaz-Curiel M, et al. Bone mineral measurements of subchondral and trabecular bone in healthy and osteoporotic rabbits. Skeletal Radiol. 2006;35(1):34–41
  23. Castaneda S, Calvo E, Largo R, Gonzalez-Gonzalez R, de la Piedra C, Diaz-Curiel M, et al. Characterization of a new experimental model of osteoporosis in rabbits. J Bone Miner Metab. 2008;26(1):53–59
  24. Covey MK, Smith DL, Berry JK, Hacker ED. Importance of cross-calibration when replacing DXA scanners: QDR4500W and Discovery Wi. J Nurs Meas. 2008;16(3):155–170
  25. Schorlemmer S, Ignatius A, Claes L, Augat P. Inhibition of cortical and cancellous bone formation in glucocorticoid-treated OVX sheep. Bone. 2005;37(4):491–496
  26. Wu ZX, Lei W, Hu YY, Wang HQ, Wan SY, Ma ZS, et al. Effect of ovariectomy on BMD, micro-architecture and biomechanics of cortical and cancellous bones in a sheep model. Med Eng Phys. 2008;30(9):1112–1118
  27. Cohen S, Levy RM, Keller M, Boling E, Emkey RD, Greenwald M, et al. Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum. 1999;42(11):2309–2318
  28. Grardel B, Sutter B, Flautre B, Viguier E, Lavaste F, Hardouin P. Effects of glucocorticoids on skeletal growth in rabbits evaluated by dual-photon absorptiometry, microscopic connectivity and vertebral compressive strength. Osteoporos Int. 1994;4(4):204–210
  29. Bagi CM, Hanson N, Andresen C, Pero R, Lariviere R, Turner CH, et al. The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: correlation with mechanical testing, pQCT and DXA. Bone. 2006;38(1):136–144
  30. Ikeda S, Tsurukami H, Ito M, Sakai A, Sakata T, Nishida S, et al. Effect of trabecular bone contour on ultimate strength of lumbar vertebra after bilateral ovariectomy in rats. Bone. 2001;28(6):625–633
  31. Akhter MP, Cullen DM, Gong G, Recker RR. Bone biomechanical properties in prostaglandin EP1 and EP2 knockout mice. Bone. 2001;29(2):121–125
  32. Ding M, Cheng L, Bollen P, Schwarz P, Overgaard S. Glucocorticoid induced osteopenia in cancellous bone of sheep: validation of large animal model for spine fusion and biomaterial research. Spine (Phila Pa 1976). 2010;1(Suppl. 1):363–370
  33. Eberhardt AW, Yeager-Jones A, Blair HC. Regional trabecular bone matrix degeneration and osteocyte death in femora of glucocorticoid-treated rabbits. Endocrinology. 2001;142(3):1333–1340
  34. Saito M, Marumo K, Soshi S, Kida Y, Ushiku C, Shinohara A. Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia. Osteoporos Int. 2009;21(4):655–666
  35. Southard TE, Southard KA, Krizan KE, Hillis SL, Haller JW, Keller J, et al. Mandibular bone density and fractal dimension in rabbits with induced osteoporosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89(2):244–249
  36. Manolagas SC, Weinstein RS. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res. 1999;14(7):1061–1066
  37. Sambrook PN. Anabolic therapy in glucocorticoid-induced osteoporosis. N Engl J Med. 2007;357(20):2084–2086
  38. Pereira RC, Delany AM, Canalis E. Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression. Bone. 2002;30(5):685–691
  39. Pereira RM, Delany AM, Canalis E. Cortisol inhibits the differentiation and apoptosis of osteoblasts in culture. Bone. 2001;28(5):484–490
  40. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998;102(2):274–282
  41. Delany AM, Gabbitas BY, Canalis E. Cortisol downregulates osteoblast alpha 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms. J Cell Biochem. 1995;57(3):488–494
  42. Ito M, Ohki M, Hayashi K, Yamada M, Uetani M, Nakamura T. Trabecular texture analysis of CT images in the relationship with spinal fracture. Radiology. 1995;194(1):55–59
  43. Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res. 2001;16(1):97–103
  44. Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum. 2003;48(11):3224–3229
  45. Lill CA, Gerlach UV, Eckhardt C, Goldhahn J, Schneider E. Bone changes due to glucocorticoid application in an ovariectomized animal model for fracture treatment in osteoporosis. Osteoporos Int. 2002;13(5):407–414

PII: S1350-4533(11)00147-0

doi: 10.1016/j.medengphy.2011.06.010

Medical Engineering & Physics
Volume 34, Issue 1 , Pages 2-8 , January 2012